3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Recruiting
4
Completed
2
Terminated
1
Not yet recruiting
1
Enrolling by invitation
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Other solid neoplasm
1
Conditions
Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Interventions
pembrolizumab
21
Cisplatin
14
Carboplatin
13
Paclitaxel
12
Radiation
11
Radiotherapy
10
Doxorubicin
10
Nivolumab
9
Cyclophosphamide
9
Cytarabine
8
Vincristine
7
Radiotherapy, Intensity-Modulated
7
Metformin
7
Magnetic Resonance Spectroscopy
7
Injections
7
Etoposide
7
Leucovorin
6
Ipilimumab
6
Fluorouracil
6
Docetaxel
6
tislelizumab
5
Specimen Handling
5
Radiotherapy, Conformal
5
Radiosurgery
5
Prednisone
5
Pemetrexed
5
Methotrexate
5
Dexamethasone
5
Cetuximab
5
Bevacizumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Patient Navigation
×
30 days
×
Clear all
NCT04234646
2026-06-02
Patient Navigation 2.0
Northwestern University
Phase NA
Completed
600 enrolled
NCT06484595
2026-05-18
GUIDE
Fred Hutchinson Cancer Center
Phase NA
Completed
100 enrolled